Showing 91-100 of 1560 results for "".
Improving the Lives of People with Sickle Cell Disease
https://reachmd.com/programs/grand-rounds-nation/improving-lives-people-sickle-cell-disease/8419/The CDC discusses Sickle Cell Disease (SCD), what we know, and how far we have come in the past few decades.Pancreas vs. Islet Cell Transplant for Diabetics
https://reachmd.com/programs/clinicians-roundtable/pancreas-vs-islet-cell-transplant-for-diabetics/1742/Join host Dr. Mark Nolan Hill in an interview with Dr. David Sutherland to learn about the pros and cons of pancreas transplant vs. islet cell transplant for patients with diabetes.GEP Testing for Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/series/updates-in-skin-cancer/gep-testing-for-cutaneous-squamous-cell-carcinoma/35599/Emily Ruiz, MD, MPH, FAAD, director of the High-Risk Cancer Clinic at Dana-Farber Cancer Institute, discusses utilizing gene expression profiling (GEP) to risk stratify tumors in cutaneous squamous cell carcinoma patients.Could T Cells Lead to New MS Treatments?
https://reachmd.com/programs/neurofrontiers/could-t-cells-lead-to-new-ms-treatments/12953/Thanks to a recent study exploring specific T cells, we might be one step closer to discovering new treatments for patients with multiple sclerosis."Google Maps" for Human Body Cells: Biology's New Frontier
https://reachmd.com/programs/conversations-on-health-care/google-maps-for-human-body-cells-biologys-new-frontier/10187/What if you had a cell map to help you gain a better understanding of the foundational elements of human health and disease?FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
https://reachmd.com/programs/project-oncology/fda-disco-osimertinib-non-small-cell-lung-cancer/9774/FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lung cancer.CRISPR in Sickle Cell: Transforming Care Through Gene Editing
https://reachmd.com/programs/project-oncology/crispr-in-sickle-cell-transforming-care-through-gene-editing/36233/CRISPR technology, while relatively new, has shown potential in treating patients with sickle cell disease by increasing fetal hemoglobin. Though this gene therapy comes with safety considerations, refinements and advancements in CRISPR technology can offer new management options for sickle cell disThe Evolving Landscape of Targeted Therapies for Non-Small Cell Lung Cancer
https://reachmd.com/programs/project-oncology/the-evolving-landscape-of-targeted-therapies-for-non-small-cell-lung-cancer/16364/Explore the latest updates in targeted therapies for non-small cell lung cancer.B-Cell Therapy: When Is It Right for Our MS Patients?
https://reachmd.com/programs/frontlines-multiple-sclerosis/b-cell-therapy-when-is-it-right-for-our-ms-patients/13722/B-cell depletion therapies have shown to prevent relapses in multiple sclerosis, but their exact role is unclear. Here’s what we know so far.Exploring Advances in Treatment: A Step Forward in Small Cell Lung Cancer
https://reachmd.com/programs/spotlight-lung-cancer/exploring-advances-in-treatment-a-step-forward-in-small-cell-lung-cancer/12593/What do we need to know about new treatment options for small cell lung cancer?